351 results on '"Powers, John J."'
Search Results
2. Optimized in vivo multispectral bioluminescent imaging of tumor biology using engineered BRET reporters
3. Sézary syndrome originates from heavily mutated hematopoietic progenitors
4. Actionable spontaneous antibody responses antagonize malignant progression in ovarian carcinoma
5. Ovarian cancer immunogenicity is governed by a narrow subset of progenitor tissue-resident memory T cells
6. TGF-β-mediated silencing of genomic organizer SATB1 promotes Tfh cell differentiation and formation of intra-tumoral tertiary lymphoid structures
7. Exposure to a mycovirus containing Aspergillus Flavus reproduces acute lymphoblastic leukemia cell surface and genetic markers in cells from patients in remission and not controls
8. The dual PI3Kδ/CK1ε inhibitor umbralisib exhibits unique immunomodulatory effects on CLL T cells
9. HDAC11 deficiency disrupts oncogene-induced hematopoiesis in myeloproliferative neoplasms
10. Silencing of HDAC6 as a therapeutic target in chronic lymphocytic leukemia
11. Interactive Media and Society Interactive Media and Society , by Corrine M. Dalelio, Lexington Books, Blue Ridge Summit, PA, 2022, 230 pp., $42.99 (paperback), ISBN: 9781793633002; $40.50 (eBook), ISBN: 9781793633019
12. A Novel Humanized Immune Stroma PDX Cancer Model for Therapeutic Studies
13. Supplementary Data from Olfactory Receptor OR2H1 Is an Effective Target for CAR T Cells in Human Epithelial Tumors
14. Supplementary Figure from Olfactory Receptor OR2H1 Is an Effective Target for CAR T Cells in Human Epithelial Tumors
15. Supplementary Figure from IgA-Dominated Humoral Immune Responses Govern Patients' Outcome in Endometrial Cancer
16. Data from Treatment of Chronic Lymphocytic Leukemia with a Hypomethylating Agent Induces Expression of NXF2, an Immunogenic Cancer Testis Antigen
17. Supplementary Data from Treatment of Chronic Lymphocytic Leukemia with a Hypomethylating Agent Induces Expression of NXF2, an Immunogenic Cancer Testis Antigen
18. Case Report: Durable complete pathologic response and organ preservation following ipilimumab and nivolumab for locally advanced primary vaginal mucosal melanoma
19. Targeting Inflammatory Pathways to Reverse Immunosuppressive Tumor Microenvironment in Chronic Lymphocytic Leukemia
20. Efficacy of Combinatorial Treatment Approaches in CTCL
21. Oncolytic immunotherapy with nivolumab in muscle-invasive bladder cancer: a phase 1b trial
22. Overexpression of TCL1 activates the endoplasmic reticulum stress response: a novel mechanism of leukemic progression in mice
23. Abstract 5496: Efficacy and immune profiling of PI3K delta inhibitor zandelisib (ME-401) in a preclinical chronic lymphocytic leukemia (CLL) model
24. Olfactory Receptor OR2H1 Is an Effective Target for CAR T Cells in Human Epithelial Tumors
25. Spontaneous class-switched antibody responses at endometrial cancer tumor bed drives superior patients’ outcome
26. CAR T cells targeting Olfactory Receptor OR2H1 are an effective immunotherapeutic option in human epithelial tumors
27. Ovarian cancer immunogenicity is governed by a narrow subset of progenitor tissue-resident memory T-cells
28. Epigenetic repolarization of T lymphocytes from chronic lymphocytic leukemia patients using 5-aza-2′-deoxycytidine
29. Restoring the functional immunogenicity of chronic lymphocytic leukemia using epigenetic modifiers
30. IgA-Dominated Humoral Immune Responses Govern Patients' Outcome in Endometrial Cancer
31. Plasma cell dependence on histone/protein deacetylase 11 reveals a therapeutic target in multiple myeloma
32. Histone deacetylase 11: A novel epigenetic regulator of myeloid derived suppressor cell expansion and function
33. SATB1 Expression Governs Follicular Helper T-cell-Triggered Tertiary Lymphoid Structure Assembly
34. Ovarian Cancer Immunogenicity is Governed by a Narrow Subset of Progenitor Tissue-Resident Memory T-Cells
35. HDAC6 Inhibition Alleviates CLL-Induced T-Cell Dysfunction and Enhances Immune Checkpoint Blockade Efficacy in the Eμ-TCL1 Model
36. Plasma of Acute Lymphoblastic Leukemia Patients React to the Culture of a Mycovirus Containing Aspergillus flavus
37. Products, general liability, and consumer law: annual survey of recent developments.
38. Selective Targeting of Histone Deacetylase 11 Disables Metabolism of Myeloproliferative Neoplasms
39. Conventional Real Time Quantitative Polymerase Chain Reaction Method Yields Similar Level of Sensitivity to Digital Droplet Polymerase Chain Reaction for Detection of BCR-ABL p210 Transcripts in Patients with Chronic Phase Chronic Myeloid Leukemia
40. Electronic discovery.
41. Functional Analysis of HDAC11 in Plasma Cell Development and Multiple Myeloma Survival
42. Loss of HDAC11 Promotes Myeloid-Derived Suppressor Cells Inhibition of T Cell Function in a Murine Lymphoma Microenvironment
43. CERTIFICATION OF ANTIBIOTICS UNDER THE FEDERAL FOOD, DRUG AND COSMETIC ACT
44. Some Aspects of Certification of Antibiotics Under the Federal Food, Drug, and Cosmetic Act
45. DISCUSSION: THE TYPHOID TOLL
46. Essential role for histone deacetylase 11 (HDAC11) in neutrophil biology
47. Interactive Media and Society: by Corrine M. Dalelio, Lexington Books, Blue Ridge Summit, PA, 2022, 230 pp., $42.99 (paperback), ISBN: 9781793633002; $40.50 (eBook), ISBN: 9781793633019.
48. A Phase I Study of Ruxolitinib Plus Nilotinib in Chronic Phase CML Patients with Molecular Evidence of Disease
49. Combinatorial Effect of HDAC6i and Ibrutinib Therapy in CLL Murine Model
50. Modulation of T Cell Compartment in a Preclinical CLL Murine Model By a Selective PI3K Delta Inhibitor, TGR-1202
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.